Laeaekaerikeskus Gyneko Oy
- Address
- Koulukatu 41, 90100 Oulu, Finland
Laeaekaerikeskus Gyneko Oy - Women's Health Research Center
Laeaekaerikeskus Gyneko Oy is a specialized clinical research center focused on women's health conditions and oncology-related complications. The center demonstrates particular expertise in investigating treatment options for symptoms associated with breast cancer therapy and hormonal changes in women.
- Vasomotor symptoms and menopausal-related conditions in cancer patients
- Hormone receptor-positive breast cancer treatment complications
- Quality of life interventions for women undergoing endocrine therapy
The center is actively involved in evaluating novel therapeutic approaches for managing vasomotor symptoms (VMS) such as hot flashes caused by adjuvant endocrine therapy. Their research addresses critical needs for women with, or at high risk for developing, hormone receptor-positive breast cancer, focusing on improving symptom management and overall quality of life during anti-cancer treatment regimens.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Chemo Research S.L.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 107 other sites in Finland
Therapeutic Area Benchmark — Finland
Select a therapeutic area to compare against other sites in Finland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Finland
Market Share
Country: Finland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Laeaekaerikeskus Gyneko Oy
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Elinzanetant in Treating Vasomotor Symptoms Induced by Adjuvant Endocrine Therapy in Hormone-Receptor Positive Breast Cancer Patients | Bayer AG, Bayer Consumer Care AG | Phase III | Not Recruiting | Oct 2022 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| DROSPIRENONE | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.